Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Haworth

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Plastic and Reconstructive Surgery|April 1, 1997
The role of the cranial base in facial growth: experimental craniofacial synostosis in the rabbitP Rosenberg, H R Arlis, R D Haworth, et al.
Biology of Reproduction|February 24, 1998
Messenger ribonucleic acid encoding monocyte chemoattractant protein-1 is expressed by the ovine corpus luteum in response to prostaglandin F2alphaJ D Haworth, M K Rollyson, P Silva, et al.
Annals of Plastic Surgery|August 1, 1992
Functional reconstruction for severe postburn microstomiaG S La Trenta, R T Grant, R D Haworth, et al.
Plastic and Reconstructive Surgery|May 1, 1992
Facial skeletal growth after timed soft-tissue underminingL S Leipziger, D S Schnapp, R D Haworth, et al.
Biology of Reproduction|March 22, 2000
Effect of dose of prostaglandin F(2alpha) on steroidogenic components and oligonucleosomes in ovine luteal tissueJ L Juengel, J D Haworth, M K Rollyson, et al.
The Review of Scientific Instruments|October 2, 2009
Microwave window breakdown experiments and simulations on the UM/L-3 relativistic magnetronB W Hoff, P J Mardahl, R M Gilgenbach, et al.
Blood Pressure|April 29, 1998
Comparison of the angiotensin II receptor antagonist irbesartan with atenolol for treatment of hypertensionK O Stumpe, D Haworth, C Hoglund, et al.
British Journal of Pharmacology|June 18, 1999
Anti-inflammatory activity of c(ILDV-NH(CH2)5CO), a novel, selective, cyclic peptide inhibitor of VLA-4-mediated cell adhesionD Haworth, A Rees, P J Alcock, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 18, 2000
Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptideA S Dutta, M Crowther, J J Gormley, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 2, 2000
Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulationA S Dutta, J J Gormley, M Coath, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Plastic and Reconstructive Surgery|April 1, 1997
The role of the cranial base in facial growth: experimental craniofacial synostosis in the rabbitP Rosenberg, H R Arlis, R D Haworth, et al.
Biology of Reproduction|February 24, 1998
Messenger ribonucleic acid encoding monocyte chemoattractant protein-1 is expressed by the ovine corpus luteum in response to prostaglandin F2alphaJ D Haworth, M K Rollyson, P Silva, et al.
Annals of Plastic Surgery|August 1, 1992
Functional reconstruction for severe postburn microstomiaG S La Trenta, R T Grant, R D Haworth, et al.
Plastic and Reconstructive Surgery|May 1, 1992
Facial skeletal growth after timed soft-tissue underminingL S Leipziger, D S Schnapp, R D Haworth, et al.
Biology of Reproduction|March 22, 2000
Effect of dose of prostaglandin F(2alpha) on steroidogenic components and oligonucleosomes in ovine luteal tissueJ L Juengel, J D Haworth, M K Rollyson, et al.
The Review of Scientific Instruments|October 2, 2009
Microwave window breakdown experiments and simulations on the UM/L-3 relativistic magnetronB W Hoff, P J Mardahl, R M Gilgenbach, et al.
Blood Pressure|April 29, 1998
Comparison of the angiotensin II receptor antagonist irbesartan with atenolol for treatment of hypertensionK O Stumpe, D Haworth, C Hoglund, et al.
British Journal of Pharmacology|June 18, 1999
Anti-inflammatory activity of c(ILDV-NH(CH2)5CO), a novel, selective, cyclic peptide inhibitor of VLA-4-mediated cell adhesionD Haworth, A Rees, P J Alcock, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|August 18, 2000
Potent cyclic monomeric and dimeric peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion based on the Ile-Leu-Asp-Val tetrapeptideA S Dutta, M Crowther, J J Gormley, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 2, 2000
Potent cyclic peptide inhibitors of VLA-4 (alpha4beta1 integrin)-mediated cell adhesion. Discovery of compounds like cyclo(MePhe-Leu-Asp-Val-D-Arg-D-Arg) (ZD7349) compatible with depot formulationA S Dutta, J J Gormley, M Coath, et al.
Pageof 3